Acute otitis media in an era of drug resistance: implications for NP practice

M A Fitzgerald1

  • 1Greater Lawrence (Mass.) Family Health Center, Boston, USA.

The Nurse Practitioner
|November 5, 1999
PubMed

Insights

Nearly two-thirds of children experience acute otitis media (AOM) by age two. Effective AOM management in pediatric primary care involves minimizing risk factors and optimizing antibiotic therapy.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Primary Care Medicine

Background:

  • Acute otitis media (AOM) is a prevalent childhood infection, affecting nearly two-thirds of children by age two.
  • AOM is a leading reason for pediatric outpatient visits and antibiotic prescriptions.
  • Effective management of AOM is crucial in pediatric primary care.

Purpose of the Study:

  • To highlight the significance of AOM in pediatric primary care.
  • To emphasize the importance of minimizing AOM risk factors.
  • To guide appropriate and effective AOM therapy while limiting unnecessary antibiotic use.

Main Methods:

  • This study is a review of current pediatric primary care practices for AOM.
  • Analysis of epidemiological data on AOM prevalence in young children.
  • Evaluation of established guidelines for AOM diagnosis and treatment.

Main Results:

  • High incidence of AOM in children under two years old.
  • AOM is a primary driver of antibiotic prescriptions in pediatric settings.
  • Optimal care requires a balanced approach to treatment and prevention.

Conclusions:

  • Minimizing AOM risk factors is essential for prevention.
  • Prescribing appropriate and effective AOM therapy is key.
  • Limiting inappropriate antimicrobial use is a critical goal in pediatric primary care.

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...